clinical trial · NCT06609161
A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)
Merck Sharp & Dohme LLC·phase1·completed·n = 18
HealthyTedizolid Phosphate Oral Formulation 1 (Reference)Tedizolid Phosphate Oral Formulation 2 (Test)
brief summary
The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the oral formulations absorption and elimination from the healthy persons body.
started
Jul 16, 2024
primary completion
Aug 8, 2024
completion
Aug 8, 2024
last updated
Sep 27, 2024
official title
A Study to Evaluate the Definitive Bioequivalence of Tedizolid Phosphate Single-Unit-Dose Sachet Powder for Oral Suspension Compared to Tedizolid Phosphate Powder for Oral Suspension Bottle Used in Pediatric Clinical Studies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol